Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Niacin for reduction of cardio...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Niacin for reduction of cardiovascular risk.
Show other versions (1)
Bibliographic Details
Main Authors:
Landray, M
,
Haynes, R
,
Armitage, J
Format:
Journal article
Language:
English
Published:
2014
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Similar Items
Niacin for reduction of cardiovascular risk.
by: Landray, M, et al.
Published: (2014)
Effects of extended-release niacin with laropiprant in high-risk patients.
by: Landray, M, et al.
Published: (2014)
The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
by: Kent, S, et al.
Published: (2016)
Fluvastatin for reduction of cardiovascular risk in patients with moderate to severe renal insufficiency.
by: Haynes, R, et al.
Published: (2007)
Niacin: old habits die hard
by: Haynes, R, et al.
Published: (2016)